Latest scientific findings give hope for people with incurable retinal degeneration
Humans rely dominantly on their eyesight. Losing vision means not being able to read, recognize faces or find objects. Macular degeneration is one of the major reasons for visual impairment, round the globe, close to 200 million people are affected. Photoreceptors in the retina are responsible to capture the light coming from the environment through the eye. Diseased photoreceptors lose their sensitivity to light, which can lead to impaired vision or even complete blindness. Scientists of the Institute of Molecular and Clinical Ophthalmology Basel (IOB) together with colleagues from the German Primate Center (DPZ) – Leibniz Institute for Primate Research in Göttingen have developed a completely new therapeutic approach based on gene therapy. They managed to activate degenerated photoreceptors using near-infrared light (Science).
The main cause of blindness in industrialized countries is the degeneration of photoreceptors, including age-related macular degeneration and retinitis pigmentosa. During the progression of degenerative photoreceptor diseases, light-sensitive and light-insensitive photoreceptor regions in the retina coexist. For example, macular degeneration patients lose vision in the central portion of their retina but retain peripheral eyesight.
Scientists have now succeeded in developing a new therapeutic approach to restore light sensitivity in degenerating retina without negatively affecting remaining vision. They were inspired by species found in nature, such as bats and snakes, that can localize near-infrared light emitted by the bodies of their preys. This is done by using heat-sensitive ion channels which are able to detect the heat of the near-infrared light. This enables the bats and snakes to superimpose thermal and visual images in the brain and thus react to their environment with greater precision. To equip retinal photoreceptors with near-infrared sensitivity, the researchers devised a three-component system. The first component contains engineered DNA that ensures that the gene coding for the heat-sensitive channel is only expressed in photoreceptors. The second component is a gold nanorod, a small particle, that efficiently absorbs near-infrared light. The third component is an antibody that ensures strong binding between the heat-sensitive channel expressed in photoreceptors and the gold nanorods that locally capture near-infrared light and locally release heat.
The researchers first tested their system in engineered mice with retinal degeneration, confirming that near-infrared light effectively excites photoreceptors and that this signal is transmitted to retinal ganglion cells, the latter representing the output of the retina towards higher visual centers in the brain. Next, they showed that stimulating the mouse eye with near-infrared light is also picked up by neurons in a brain area that is important for conscious vision, the primary visual cortex. They also designed a behavioral test in which untreated blind mice were not able to use near-infrared stimulation to learn a simple task whereas blind mice treated with the three-component system could perform the task related to near-infrared stimulus.
In collaboration with Arnold Szabo, a co-author of the paper and Assistant Professor at the Semmelweis University in Hungary, the researchers could test their new approach on human retinas that can be kept alive in culture medium for months, though blindness sets in a day or so after death by photoreceptors losing their ability to detect light. Experimental results showed that following treatment with the three-component gene therapy method, near-infrared light exposures reactivated the human retina’s visual circuitry.
“We believe that near-infrared stimulation is an important step towards providing useful vision to blind patients so that they can regain their ability to read or see faces”, says Daniel Hillier, head of the junior research group Visual Circuits and Repair at DPZ, and adds: “We want to give hope to blind people with these findings and will further intensify our research activities in this area here at DPZ within our main project, which focuses on the restoration of vision.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Gene therapy to restore vision
- Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for a number of highly prevalent ocular diseases with the aspiration of ...
- Progress toward a stem cell–based therapy for blindness
What if, in people with blinding retinal disorders, one could simply introduce into the retina healthy photoreceptor cells derived in a dish from stem cells, and restore sight?
- Phase 2 gene therapy trial for Stargardt disease underway
may have much greater potential to restore lost vision.” The therapy uses vector and promoter technology to deliver the multi-characteristic opsin genes into retinal bipolar cells, reprograming ...
- Nanoscope begins patient dosing in STARLIGHT phase 2 trial of MCO-010 optogenetic gene therapy for Stargardt disease
Nanoscope begins patient dosing in STARLIGHT phase 2 trial of MCO-010 optogenetic gene therapy for Stargardt disease: Dallas Tuesday, July 26, 2022, 18:00 Hrs [IST] Nanoscope Ther ...
- The FDA Approves a New Gene Therapy Treatment for a Rare Form of Blindness
The U.S. Food and Drug Administration (FDA) has approved the use of a new form of gene therapy that targets ... signal in the retina to restore patient’s vision loss." Treatment has to be ...
Go deeper with Google Headlines on:
Gene therapy to restore vision
Go deeper with Bing News on:
Incurable retinal degeneration
- Scientists Discover Genetic Clues That Can Lead To Better Treatment For Blindness-Causing Conditions
By Simona Kitanovska Better treatments for an eye condition that can cause blindness are a major step closer after scientists discovered genetic clues that show who has it. Researchers in Australia ...
- Scientists Discover Genetic Clues Related to Treating Macular Degeneration
Better treatments for an eye condition that can cause blindness are a major step closer after scientists discovered genetic clues that show who has it. Researchers in Australia have unearthed genetic ...
- Better treatments for eye condition that can cause blindness on horizon
To make the breakthrough, the team reprogrammed stem cells to models of diseased eye cells. The post Better treatments for eye condition that can cause blindness on horizon appeared first on Talker.
- Molecular Signatures of Age-Related Macular Degeneration Identified
The discovery of molecular signatures of the incurable eye disease, age-related macular degeneration, could improve diagnosis and treatment.
- Clues to age-related macular degeneration revealed
Better diagnosis and treatment of the incurable eye disease age-related macular degeneration is a step closer, thanks to the discovery of new genetic signatures of the disease. Scientists from the ...